These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 1685349

  • 1. Intrathecal administration of dynorphin A and its fragments increase heart rate and arterial pressure in the urethane anesthetized rat: mediation by a nonopioid mechanism.
    Rochford J, Godin C, Henry JL.
    Brain Res; 1991 Nov 22; 565(1):67-77. PubMed ID: 1685349
    [Abstract] [Full Text] [Related]

  • 2. Intrathecal administration of delta receptor agonists in the urethane anesthetized rat provokes an increase in arterial pressure via a non-opioid mechanism.
    Rochford J, Henry JL.
    Brain Res; 1990 Apr 02; 512(2):259-68. PubMed ID: 2162234
    [Abstract] [Full Text] [Related]

  • 3. Comparative effects of intrahippocampal injection of dynorphin A(1-8), dynorphin A(1-13), dynorphin A(1-17), U-50,488H, and dynorphin B on blood pressure and heart rate in spontaneously hypertensive and normotensive Wistar-Kyoto rats.
    Wang JQ, Ingenito AJ.
    Peptides; 1994 Jan 02; 15(1):125-32. PubMed ID: 7912425
    [Abstract] [Full Text] [Related]

  • 4. Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity.
    Stevens CW, Yaksh TL.
    J Pharmacol Exp Ther; 1986 Sep 02; 238(3):833-8. PubMed ID: 2875172
    [Abstract] [Full Text] [Related]

  • 5. Opiate and alpha receptor antagonists block the pressor responses of conscious rats given intravenous dynorphin.
    Thornhill JA, Gregor L, Saunders WS.
    Peptides; 1989 Sep 02; 10(1):171-7. PubMed ID: 2568623
    [Abstract] [Full Text] [Related]

  • 6. Kappa agonists inhibit gastric emptying but not acid secretion in rhesus monkeys.
    Touzeau PL, Shea-Donohue T.
    J Pharmacol Exp Ther; 1990 Jun 02; 253(3):1010-6. PubMed ID: 1972746
    [Abstract] [Full Text] [Related]

  • 7. Dynorphin selectively augments the M-current in hippocampal CA1 neurons by an opiate receptor mechanism.
    Madamba SG, Schweitzer P, Siggins GR.
    J Neurophysiol; 1999 Oct 02; 82(4):1768-75. PubMed ID: 10515966
    [Abstract] [Full Text] [Related]

  • 8. Effects of selective and non-selective kappa-opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neurones.
    Knox RJ, Dickenson AH.
    Brain Res; 1987 Jul 07; 415(1):21-9. PubMed ID: 2887243
    [Abstract] [Full Text] [Related]

  • 9. Intrathecal dynorphins suppress hindlimb electromyographic activity in rats.
    Stevens CW, Weinger MB, Yaksh TL.
    Eur J Pharmacol; 1987 Jun 19; 138(2):299-302. PubMed ID: 2887441
    [Abstract] [Full Text] [Related]

  • 10. The effects of dynorphin A (1-13) and U50, 488H on free intracellular calcium in guinea pig cerebellar synaptosomes.
    Olson KG, Welch SP.
    Life Sci; 1991 Jun 19; 48(6):575-81. PubMed ID: 1671526
    [Abstract] [Full Text] [Related]

  • 11. [Intrathecal co-administration of kappa opioid receptor agonists and NMDA receptor antagonists induces synergistic analgesia in rats].
    Li FC, Sun XJ, Hu WH, Jen MF.
    Yao Xue Xue Bao; 1994 Jun 19; 29(12):881-6. PubMed ID: 7709739
    [Abstract] [Full Text] [Related]

  • 12. Microinjection of dynorphin into the supraoptic and paraventricular nuclei produces antidiuretic effects through vasopressin release.
    Tsushima H, Mori M, Matsuda T.
    Jpn J Pharmacol; 1993 Dec 19; 63(4):461-8. PubMed ID: 7907154
    [Abstract] [Full Text] [Related]

  • 13. Cardioacceleration provoked by intrathecal administration of vasoactive intestinal peptide (VIP): mediation by a non-central nervous system mechanism.
    Rochford J, Henry JL.
    Neuropeptides; 1989 Dec 19; 14(4):243-52. PubMed ID: 2482950
    [Abstract] [Full Text] [Related]

  • 14. Opioid and nonopioid mechanisms may contribute to dynorphin's pathophysiological actions in spinal cord injury.
    Faden AI.
    Ann Neurol; 1990 Jan 19; 27(1):67-74. PubMed ID: 1967925
    [Abstract] [Full Text] [Related]

  • 15. Participation of central kappa-opioid receptor in arrhythmogenesis.
    Lishmanov YB, Maslov LN, Ugdyzhekova DS, Smagin GN.
    Life Sci; 1997 Jan 19; 61(3):PL33-8. PubMed ID: 9217295
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of lipopolysaccharide-induced nitric oxide and cytokine production by ultralow concentrations of dynorphins in mixed glia cultures.
    Kong LY, McMillian MK, Hudson PM, Jin L, Hong JS.
    J Pharmacol Exp Ther; 1997 Jan 19; 280(1):61-6. PubMed ID: 8996182
    [Abstract] [Full Text] [Related]

  • 17. Intrathecal administration of calcitonin gene-related peptide (CGRP) increases heart rate and decreases arterial pressure in the urethane anesthetized rat.
    Rochford J, Yashpal K, Henry JL.
    Brain Res Bull; 1990 Dec 19; 25(6):809-16. PubMed ID: 1981173
    [Abstract] [Full Text] [Related]

  • 18. Dynorphin A-(1-17) induces alterations in free fatty acids, excitatory amino acids, and motor function through an opiate-receptor-mediated mechanism.
    Bakshi R, Newman AH, Faden AI.
    J Neurosci; 1990 Dec 19; 10(12):3793-800. PubMed ID: 1980130
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
    Scheurer U, Wenger F, Caliezi A, Drack E, Varga L, Halter F.
    J Pharmacol Exp Ther; 1990 Mar 19; 252(3):1324-30. PubMed ID: 1969475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.